Literature DB >> 30363979

Multiple liver masses in a patient with breast cancer, metastasis or not? An unexpected diagnosis: hepatic fascioliasis. A case report and overview of the literature from Turkey.

Çağri Damar1, Arif Emre Emek2, Hüseyin Uçar3, Harun Erdal4, Işik Conkbayir5, Çiğdem Öztunali1.   

Abstract

A patient who underwent mastectomy of the left breast owing to breast cancer was referred to our department for abdominal ultrasonography during her routine check-up. Radiological examinations demonstrated multiple masses that tended to form clusters in the liver parenchyma, and the lesions were initially thought to represent metastases from the breast cancer. Multisite biopsies and serological tests confirmed the diagnosis of Fasciola hepatica infestation. To our knowledge, this is a unique case report of a patient with a known malignant neoplasm. We also present an overview of the literature about human fascioliasis in Turkey.

Entities:  

Year:  2016        PMID: 30363979      PMCID: PMC6183218          DOI: 10.1259/bjrcr.20160038

Source DB:  PubMed          Journal:  BJR Case Rep        ISSN: 2055-7159


Summary

Owing to their long historical background, environmental and climatic features, biodiversity and proximity of the people to animals some zoonotic diseases are seen more frequently in the countries of the Mediterranean and the Middle East.[1] Fasciola hepatica is a foodborne trematode worm (fluke) that mainly affects the liver of its final host. Its human infestation can be seen in Anatolia (the western peninsula of Asia that forms the mainland of Turkey). As its radiological findings may mimic metastases, it is important to consider F. hepatica in the differential diagnosis while evaluating imaging findings of patients with previously known malignancy. We herein present the case of a 38-year-old female patient with a history of breast cancer who had presented with multiple liver lesions that were finally proven to be consistent with fascioliasis.

Case Report

A 38-year-old female who had undergone right mastectomy for breast carcinoma was referred to our department for evaluation of the multiple liver masses detected on routine follow-up examinations. Sonographic examination of the patient revealed hepatosplenomegaly and multiple heterogeneous hypoechoic masses of varying sizes that were located centrally in the right lobe of the liver and tended to form clusters. Some of the larger lesions had central necrosis and cavitation areas (Figure 1). We observed hypoechoic curvilinear tracts extending from the liver capsule to the parenchyma, which did not demonstrate abnormal vascularity on colour Doppler ultrasound examination (Figure 2). The gallbladder had normal wall thickness and endoluminal echogenicity.
Figure 1.

Ultrasound image of the liver shows multiple, ill-defined hypoechoic confluent nodular masses (chevron arrows). Note the central necrosis area in one of the larger-sized lesions (large arrow).

Figure 2.

Ultrasound image of the liver reveals poorly defined hypoechoic subcapsular area and a tortuous tract, extending from the capsule to the deeper parenchyma (arrowheads).

Ultrasound image of the liver shows multiple, ill-defined hypoechoic confluent nodular masses (chevron arrows). Note the central necrosis area in one of the larger-sized lesions (large arrow). Ultrasound image of the liver reveals poorly defined hypoechoic subcapsular area and a tortuous tract, extending from the capsule to the deeper parenchyma (arrowheads). Contrast-enhanced CT obtained in the portal venous phase revealed multiple, clustered, hypodense nodular liver masses with irregular margins (Figure 3). In addition, the presence of at least three hypodense curvilinear tracts, extending from the liver capsule to the parenchyma, were confirmed (Figure 4). The lesions did not demonstrate any contrast enhancement. There were a number of enlarged lymph nodes in the porta hepatis.
Figure 3.

Contrast-enhanced CT images in the portal phase show multiple small, clustered hypodense nodular masses with hazy irregular margins in the right lobe of the liver parenchyma (arrows).

Figure 4.

Contrast-enhanced CT images in the portal phase demonstrate two hypodense curvilinear tracts, extending from the liver capsule to the parenchyma, in the hepatic segments V and VI (arrows).

Contrast-enhanced CT images in the portal phase show multiple small, clustered hypodense nodular masses with hazy irregular margins in the right lobe of the liver parenchyma (arrows). Contrast-enhanced CT images in the portal phase demonstrate two hypodense curvilinear tracts, extending from the liver capsule to the parenchyma, in the hepatic segments V and VI (arrows). Ultrasound-guided fine needle aspirations of the selected lesions were performed. Pathological examination of the specimens showed no evidence of malignancy but eosinophil-rich inflammatory necrotic tissue was reported. Blood tests also revealed elevated levels of eosinophils and serological tests confirmed the presence of F. hepatica infestation. The patient was discharged after a course of triclabendazole treatment. A follow-up CT scan, obtained 2 years after her first admission, showed slight regression in the size of all the liver lesions (Figure 5 and Supplementary Video A and there were no new lesions.
Figure 5.

Post-treatment contrast-enhanced CT image in the portal phase 2 years later shows that the liver lesions had slightly regressed in size.

Post-treatment contrast-enhanced CT image in the portal phase 2 years later shows that the liver lesions had slightly regressed in size.

Discussion

Fascioliasis is included in the group of food (or snail)-borne trematodiases and is caused by two species of parasitic flatworms: F. hepatica and Fasciola gigantica.[2]

Epidemiology

Although the natural final hosts of this parasite are sheep, goats, cattles and other herbivores, F. hepatica has been reported in humans with increasing frequency. Despite the belief that it has a European origin, F.hepatica has shown a great capacity to spread and can be seen in all the continents except Antarctica. According to the recent estimates, several million people are infected in more than 70 countries worldwide, with millions of others being at risk. The parasite can easily adapt and colonize in rural areas and wetlands, where there are plenty of freshwater Lymnaea snails (the intermediate hosts) and herbivorous mammals (the definitive hosts). However, human fascioliasis (HF) has a patchy geographical distribution and there are some endemic regions such as the Caribbean, northern Africa, western Europe and the Caspia. Certainly, the lifestyle and dietary habits of the people, social and economic factors, hygiene and sanitation conditions, and travel or immigration, all add to the frequency of the disease. If it is detected in some livestock animals, human cases may also exist.[2-6]

Lifecycle of parasites

The eggs of the parasite are excreted with the final host's faeces. These eggs are immersed in freshwater, and the swimming, ciliated miracidia forms are released. Miracidiae use Lymnaea snails as their first host; once they metamorphose into motile, tailed cercaria forms, they leave the snails. Cercariae use the aquatic plants (watercress, watermint, lettuce, spinach orother salad vegetables) as another group of intermediate hosts; the cercarial larvae encyst and develop into the metacercarial stage. The main transmission of F. hepatica occurs by ingesting water or raw plants contaminated by the metacercaria forms of the parasite. The metacercariae change form during duodenal interference; they penetrate the intestinal wall and migrate through the peritoneal cavity to reach the Glisson’s capsule. After piercing the capsule of the liver, the parasites migrate through the liver parenchyma and reach the biliary system, where they grow into adults and release new eggs. The eggs reach the intestines via bile and are evacuated in the faeces, thus completing the transmission cycle of the parasites. The average size of a mature fluke is 20–40 mm in length and 8–13 mm in width.[6-8]

Human infestation, clinical features, diagnosis and treatment

Human infestation by this trematode has two characteristic phases: an acute hepatic (parenchymal) phase and a chronic biliary (ductal) phase.[6,7] The first phase is the hepatic phase. In this phase, the parasites pierce the Glisson’s capsule and migrate through the liver parenchyma towards the bile ducts in a random manner. This stage lasts for 1–3 months after metacercariae infection. The clinical features of this stage include anorexia, fatigue, nausea, vomiting, right upper quadrant pain, pruritus, fever, weight loss, respiratory symptoms, hepatomegaly, jaundice and urticaria. Laboratory findings such as elevated liver enzymes, increased erythrocyte sedimentation rate, hypergammaglobulinaemia and marked eosinophilia can be encountered in this stage as well. Mild hepatitis, severe hepatic subcapsular haemorrhage or liver necrosis may also be seen rarely in this hepatic phase.[6,7] The second stage may be asymptomatic for a long time or may be characterized by intermittent right upper quadrant pain. As a result of chronic inflammation of the bile ducts, ductal wall thickening, common bile duct obstruction, bile duct stones or gallstones, cholestasis, cholangitis, cholecystitis or pancreatitis may occur.[6,7,9] Adult flukes can live for years and the chronic phase may persist in untreated patients.[8,10] F. hepatica can rarely settle in unusual organs and lead to ectopic disease.[8,11-13] Suggested diagnostic criteria for fascioliasis in endemic regions, reported by the WHO in 2009, are:[14] history of eating raw aquatic plants clinical symptoms such as abdominal pain in the epigastric or right-upper quadrant region, lasting at least a week eosinophilia positive ultrasound or CT scan findings positive for the presence of F. hepatica eggs (detected by Kato–Katz thick smear or sedimentation technique) positive serologic tests (from the serum, stool or urine specimens). For the treatment of the cases diagnosed with the above-mentioned criteria, the recommended drug triclabendazole (10 mg kg−1 of body weight) is given in a single administration. If necessary, a double dose (20 mg kg−1 of body weight) can be administered for the management of individual cases.[14]

Radiological findings

When the flukes follow the migration path from the liver capsule to the bile ducts, they ingest hepatocytes. Along this migration path, multiple small necrotic cavities and microabscesses arise. These abscess cavities are not large, as seen in the cases of other suppurative processes. On CT imaging, migration paths that extend from the Glisson's capsule to deep parenchymal areas (tunnel-like tracts) can be seen. Also, serpentine, clustered, small necrotic cavities can be detected. These two findings, which were also observed in our case, are defined as the “tunnels and caves sign” in the literature[10] and can help in separating other malignant lesions from these parasitic lesions. In addition, the peripheral halo sign on B-mode ultrasound examination and internal vascularity on colour Doppler mode sonography or contrast-enhanced CT imaging, which are usually seen in cases of metastatic nodules, were not present in our case.[15] With the use of ultrasound imaging, adult worms can be visualized in the gallbladder and/or in the extrahepatic bile ducts. Ultrasound examination may demonstrate single or multiple, elongated filamentous structures or moving echogenic flukes.[10] Adult forms of parasites attach to the inner wall of the bile duct through their ventral suckers.[9,10]  When we retrospectively re-examined our patient, we detected a thin, linear echogenicity 1.5 cm long, one end of which was fixed to the posterior wall of the common bile duct (Figure 6). Although this appearance was also consistent with the previously described sonographic appearances of the adult parasites in the literature,[8,16] we did not perform any further investigations because the patient had already been diagnosed with the infection and there were no signs of cholestasis that would have required further endoscopic intervention. There are also some reports that stress the importance of endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis and treatment of the chronic phase of the disease. In cases of cholestasis, adult parasites can be seen in the biliary tract and ERCP enables the removal of the parasites.[17] In ERCP or MR cholangiography, the flukes are seen as filling defects in the bile ducts.[8,17,18]
Figure 6.

Ultrasound image reveals a thin, linear echogenicity, which is fixed at one end to the posterior wall of the common bile duct.

Ultrasound image reveals a thin, linear echogenicity, which is fixed at one end to the posterior wall of the common bile duct. Periportal lymphadenopathies may be accompanied by other radiological findings, as in our case.[15] Other cases of hepatobiliary fascioliasis mimicking cholangiocellular or hepatocelluler carcinoma or Oddi sphincter malignancy have been reported. Extrahepatic fascioliasis mimicking colon, ovarian, peritoneal carcinoma, or liver metastases of unknown origin have also been reported in the literature.[19-27] However, only one case of hepatic fascioliasis has been reported in a patient with breast carcinoma by Koc et al[28] in 2009. The patient was asymptomatic and only choledochal dilatation was found incidentally during abdominal ultrasound examination; without any other suspicious imaging findings of metastasis. To our knowledge, except for our report, there is no other report of HF mimicking liver metastases in a patient being followed up for breast carcinoma.

HF in Turkey

HF is a re-emerging disease and common in some provinces of Turkey[29] (Table 1). There are many published reports of human FH infections coming from these regions (Table 2), and also there are some case reports related to European travellers.[30-33F. gigantica does not have the ability to spread like F. hepatica, but can be seen infrequently in Turkey.[4] There are only two case reports of biliary F. gigantica, which is distinguished from F. hepatica with its morphological features.[34,35]
Table 1.

Publications reporting the prevalence of human fascioliasis (HF) in some regions of Turkey

Author (year)City/ RegionNumber of selected individualsNumber of detected HFPrevalence
Serological tests (%)Stool tests (%)
Yilmaz et al[36] (1997)Van/Eastern Anatolia3.534a (14 years and above)10.028
Yilmaz et al[37] (1998)Ercis (Van)/Eastern Anatolia206a (students, 7–15 years age group)52.43
Yilmaz et al[38] (1999)Ercis (Van)/Eastern Anatolia293a20.68
Yilmaz et al[39] (2004)Ercis (Van)/Eastern Anatolia50091.8
Yilmaz et al[40] (2007)Ercis (Van)/Eastern Anatolia867a10,1
Tas Cengiz et al[41] (2009)Van/Eastern Anatolia2.975a10.03
Tas Cengiz et al[42] (2015)Van/Eastern Anatolia1.600895.61,8
Tas Cengiz et al[43] (2015)Van/Eastern Anatolia5.985a80.1
Sener et al[44] (1998)Ankara/Central Anatolia122.400a10.0009
Kaplan et al[45] (2002)Elazıg/Eastern Anatolia540152.78
Seker et. al[46] (2005)Bagtepe (Adana)/Mediterranean2913010.3
Turhan et al[47] (2006)Antalya (10 suburbs)/Mediterranean597183
Demirci et al[48] (2003)Isparta/Mediterranean756, with eosinophilia466.1
320, others30.9
Kaya et al[49] (2006)Isparta/Mediterranean415102.4
A. Gokdere (Isparta)/Mediterranean171169.3
Ozturhan et al[50] (2009)Mersin/Mediterranean155, with a family history of HF31.93
729, others40.55
Sahin et al [51] (2008)Karpuzeskisi (Kayseri)/Central Anatolia374133.48
Koksal et al[52] (2010)Istanbul/Marmara27.664a10.003
Zeren et al[53] (2013)Cukurova (Adana)/Mediterranean94, with blood samples obtained during forensic autopsies1313.8
Tas et al[54] (2014)Bolu/Black Sea2.595a10.039
Karaman et al[55] (2014)Ordu/Black Sea7.194a170.23

The study includes not only HF but also other parasitoses.

Table 2.

The other publications on human fascioliasis from Turkey, including at least five or more cases

Author (year)Hospital/department of the corresponding authorCity/regionNumber of casesDate range
Kabaalioglu et al[15] (2007)Akdeniz UMH/radiologyAntalya/Mediterranean87a1995–2006
Saba et al[56] (2004)Akdeniz UMH and other centers/infectious siseasesAntalya/Mediterranean531998– 2003
Cevikol et al[57] (2003)Akdeniz UMH/radiologyAntalya/Mediterranean431995– 2001
Cubuk et al[58] (2001)Akdeniz UMH/radiologyAntalya/Mediterranean521995– 2000
Sakru et al[59] (2004)Trakya UMH and other centers/microbiologyİzmir, Antalya/Aegean, Mediterranean37b?–2004
Taylan Ozkan et al[60] (2005)Ege UMH and other centers/parasitologyİzmir, Antalya/Aegean, Mediterranean14?–2005
Sezgi et al[61] (2013)Dicle UMH/pulmonary diseaseDiyarbakir/South-Eastern Anatolia562010–2011
Teke et al[62] (2014)Dicle UMH/radiologyDiyarbakir/South-Eastern Anatolia452011–2013
Basarili et al[63] (2011)Dicle UMH/biochemistryDiyarbakir/South-Eastern Anatolia452010–2011
Kaya et al[64] (2013)Dicle UMH/gastroenterologyDiyarbakir/South-Eastern Anatolia42c2010–2012
Ulger et al[65] (2014)Dicle UMH/general surgeryDiyarbakir/South- Eastern Anatolia392005–2013
Demirkaya et al[66] (2014)Dicle UMH/microbiologyDiyarbakir/South-Eastern Anatolia132011–2012
Demirci et al[67] (2009)Suleyman Demirel UMH/microbiologyIsparta/Mediterranean50d?–2009
Yesildag et al[16] (2009)Suleyman Demirel UMH/radiologyIsparta/Mediterranean272001–2006
Avcu et al[18] (2009)Van Yuzuncu Yil UMH/radiologyVan/Eastern Anatolia242008
Karahocagil et al[68] (2011)Van Yuzuncu Yil UMH/infectious diseaseVan/Eastern Anatolia242008
Aksoy et al[69] (2006)Hacettepe UMH/internal medicineAnkara/Central Anatolia101998–2005
Karadag-Oncel et al[70] (2012)Hacettepe UMH/pediatric infectious diseaseAnkara/Central Anatolia52005–2011
Kayabalı et al[71] (1992)Ankara UMH/general surgeryAnkara/Central Anatolia7?–1992
Tezer et al[72] (2013)Gazi UMH and other centers/pediatric infectious diseaseAnkara/Central Anatolia62008–2012
Tetik et al[73] (1995)Ankara Diskapi ERH/general surgeryAnkara/Central Anatolia5?–1995
Sezgin et al[74] (2004)Mersin UMH and other centers/gastroenterologyMersin/Mediterranean91996–2002
Parsak et al[75] (2006)Cukurova UMH/general surgeryAdana/Mediterranean102000–2006
Koc et al[28] (2009)Baskent UMH/radiologyAdana/Mediterranean52003–2007
Gulsen et al[76] (2006)Gaziantep UMH/internal medicineGaziantep/South-Eastern Anatolia52000–2003

ERH, Education and Research Hospital; UMH, University Medical Hospital.

The largest case series described in one of the five publications (1999–2013) of the author. 

The largest case series described in one of the two publications (2004, 2011) of the author. 

The largest case series described in one of the three publications (2011–13) of the author. 

The largest case series described in one of the seven publications (2002–09) of the author.

Note: The published case series from the same centres may overlap.

The disease continues to attract a large number of physicians who are studying in different departments in Turkey. Publications reporting the prevalence of human fascioliasis (HF) in some regions of Turkey The study includes not only HF but also other parasitoses. The other publications on human fascioliasis from Turkey, including at least five or more cases ERH, Education and Research Hospital; UMH, University Medical Hospital. The largest case series described in one of the five publications (1999–2013) of the author. The largest case series described in one of the two publications (2004, 2011) of the author. The largest case series described in one of the three publications (2011–13) of the author. The largest case series described in one of the seven publications (2002–09) of the author. Note: The published case series from the same centres may overlap.

Conclusions

Hepatobiliary fascioliasis should be kept in mind in the differential diagnosis of multiple hepatic masses when suggestive clinical and laboratory findings are present, especially when the patients come from the endemic regions. Knowledge of the radiological imaging characteristics of HF can aid in the diagnosis, and imaging is also useful in the evaluation of the treatment response. F. hepatica infestation must be considered in case of patients with a history of eating raw aquatic plants (watercress, etc.) in endemic regions who present with right upper quadrant pain, eosinophilia and multiple hepatic lesions. Hepatobiliary fascioliasis can mimic primary or secondary hepatic malignancies. “Tunnels and caves sign” is a finding of HF in radiological examinations.

Consent

Written informed consent was obtained from the patient for publication of this case report, including accompanying images.
  50 in total

1.  The prevalence of intestinal parasite infections among schoolchildren of Van province, Turkey.

Authors:  Hasan Yilmaz; Filiz Arabaci; Nalan Ozdal; Zeynep Taş; Sahin Metin; Ozlem Orunç
Journal:  Trop Doct       Date:  2007-04       Impact factor: 0.731

2.  [Multiple liver lesions accompanied by eosinophilia - a case report of fascioliosis].

Authors:  Eva Trifina; Johannes Spenger; Shahin Zandieh; Jörg Haller; Herbert Auer; Christian Osterreicher; Klaus Klaushofer; Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2011-09

3.  [Intestinal parasitoses detected in primary schoolchildren in the Van province].

Authors:  Zeynep Taş Cengiz; Sinan Akbayram; Mutalip Ciçek; Hasan Yilmaz
Journal:  Turkiye Parazitol Derg       Date:  2009

4.  Seroprevalence of fasciolosis and the difference of fasciolosis between rural area and city center in Isparta, Turkey.

Authors:  Selcuk Kaya; Mustafa Demirci; Reha Demirel; Buket C Aridogan; Mustafa Ozturk; Metin Korkmaz
Journal:  Saudi Med J       Date:  2006-08       Impact factor: 1.484

5.  An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma.

Authors:  Ebubekir Şenateş; Abdullah Doğan; Banu Erkalma Şenates; Erdal Bodakçi; Muhammet Bekçibasi
Journal:  Infez Med       Date:  2014-12

Review 6.  Epidemiology of human fascioliasis: a review and proposed new classification.

Authors:  M S Mas-Coma; J G Esteban; M D Bargues
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

7.  [Comparison of two different enzyme immunoassays in the diagnosis of Fasciola hepatica infections].

Authors:  Nermin Sakru; Metin Korkmaz; H Aydinten Kuman
Journal:  Mikrobiyol Bul       Date:  2004 Jan-Apr       Impact factor: 0.622

8.  Human fascioliasis: MR imaging findings of hepatic lesions.

Authors:  Can Cevikol; Kamil Karaali; Utku Senol; Adnan Kabaalioğlu; Ali Apaydin; Rabin Saba; Ersin Lüleci
Journal:  Eur Radiol       Date:  2002-06-05       Impact factor: 5.315

9.  Cholestasis caused by Fasciola gigantica.

Authors:  Remzi Beştaş; Kendal Yalçin; Muttalip Çiçek
Journal:  Turkiye Parazitol Derg       Date:  2014

Review 10.  Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis.

Authors:  Jae Hoon Lim; Eimorn Mairiang; Geung Hwan Ahn
Journal:  Abdom Imaging       Date:  2008 Mar-Apr
View more
  1 in total

Review 1.  Oxysterols of helminth parasites and pathogenesis of foodborne hepatic trematodiasis caused by Opisthorchis and Fasciola species.

Authors:  Nuno Vale; Maria João Gouveia; Fátima Gärtner; Paul J Brindley
Journal:  Parasitol Res       Date:  2020-03-23       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.